A new AI tool to more quickly and accurately classify brain tumours has been developed by researchers at The Australian National University (ANU). 

 According to Dr Danh-Tai Hoang, precision in diagnosing and categorising tumours is crucial for effective patient treatment. 

“The current gold standard for identifying different kinds of brain tumours is DNA methylation-based profiling,” Dr Hoang said. 
 
“DNA methylation acts like a switch to control gene activity, and which genes are turned on or off.  

 “But the time it takes to do this kind of testing can be a major drawback, often requiring several weeks or more when patients might be relying on quick decisions on therapies

“There’s also a lack of availability of these tests in nearly all hospitals worldwide.”  

To address these challenges, the ANU researchers, in collaboration with experts from the National Cancer Institute in the United States (US), developed DEPLOY, a way to predict DNA methylation and subsequently classify brain tumours into 10 major subtypes. 
 
DEPLOY draws on microscopic pictures of a patient’s tissue called histopathology images.    

The model was trained and validated on large datasets of approximately 4,000 patients from across the US and Europe.  

“Remarkably, DEPLOY achieved an unprecedented accuracy of 95 per cent,” Dr Hoang said. 

“Furthermore, when given a subset of 309 particularly difficult to classify samples, DEPLOY was able to provide a diagnosis that was more clinically relevant than what was initially provided by pathologists. 

“This shows the potential future role of DEPLOY as a complementary tool, adding to a pathologist’s initial diagnosis, or even prompting re-evaluation in the case of disparities.” 

The researchers believe DEPLOY could eventually be used to help classify other types of cancer as well.  

The research has been published in Nature Medicine. 

Top image: Dr Danh-Tai Hoang. Photo: Dave Fanner/ANU

You may also like

Article Card Image

What are quaaludes? Should you be worried they’ve been detected in Canberra?

Working alongside ANU scientists, we detected a recreational sedative – methylmethaqualone – circulating in Canberra for the first time. But a novel street drug is rarely as new as it seems.

Article Card Image

You are what you eat: research investigates how gut health affects the mind

New research patterns show the connection between our gut health, our mental health and even our personality traits.

Article Card Image

Review led by ANU Professor highlights potential to ‘unleash’ Australia’s health workforce

An ANU-led review has found Australia’s health professionals face restrictions and barriers that are impacting the level of care they’re able to provide patients.

Subscribe to ANU Reporter